NYSE · Analyst Forecast

Johnson & Johnson (JNJ) Stock Forecast & Price Target

$283.07 NYSE: JNJ Market Cap $681.44B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Johnson & Johnson (JNJ), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Johnson & Johnson, analysts forecast revenue rising from $93.76B in 2025 to $135.29B in 2030; the average estimate for 2030 earnings per share is $17.55; with published estimates ranging from $17.29 to $17.86; 18 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$283.07
Consensus targetThe average of the price targets analysts have published.$285.31
Median targetThe middle target, less affected by a single outlier.$281.00
Highest targetThe most optimistic published target.$320.00
Lowest targetThe most pessimistic published target.$260.00
Difference from priceHow far the consensus target sits from today’s price.+0.8%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$93.61B$93.76B$94.03B17
2026$100.84B$101.22B$101.49B16
2027$105.88B$107.76B$109.43B16
2028$113.87B$116.59B$120.07B18
2029$123.91B$125.32B$127.06B9
2030$133.78B$135.29B$137.17B17

Earnings per share forecast

YearLowAverageHighAnalysts
2025$10.72$10.80$10.8417
2026$11.04$11.11$11.2016
2027$10.69$11.59$12.3116
2028$13.43$13.96$15.5518
2029$15.39$15.62$15.909
2030$17.29$17.55$17.8617

Johnson & Johnson (JNJ) forecast — frequently asked questions

What is the analyst price target for Johnson & Johnson?

Analysts covering Johnson & Johnson (JNJ) have a consensus price target of $285.31, 0.8% above the current price of $283.07. Published targets range from $260.00 to $320.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Johnson & Johnson's earnings?

The average analyst estimate for Johnson & Johnson (JNJ) earnings per share in 2030 is 17.55, with individual estimates between 17.29 and 17.86.

How much revenue is Johnson & Johnson expected to make?

Analysts forecast Johnson & Johnson (JNJ) revenue of $135.29B in 2030, based on 17 published estimates.

How many analysts cover JNJ?

18 analysts contribute estimates for Johnson & Johnson (JNJ). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastABBV forecastMRK forecastNVS forecastAZN forecastAMGN forecastGILD forecastNVO forecastPFE forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.